{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:08:31Z","timestamp":1790208511561,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Current Oka strain varicella vaccines are generally safe but may cause latent neuronal infections leading to herpes zoster in some vaccinees. A novel v7D candidate vaccine has been developed to prevent varicella and reduce these risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This randomized, double-blind, controlled, phase 2b clinical trial was conducted in Jiangsu, China. Healthy children 1\u201312 years old with no history of varicella infection or vaccination were enrolled and randomly assigned to 0\u20133-\/6-month schedule for low\/medium dose. Phase 2a participants (3\u201312 years of age) previously receiving low-\/medium-\/high-dose v7D or licensed vOka received a second dose in phase 2b (0\u201315-month schedule) for exploratory analysis. The primary outcome was immunogenicity via varicella-zoster virus immunoglobulin (Ig)G seroconversion and geometric mean titers at 30 and 90 days post-second vaccination. This study was registered on Chinese Clinical Trial Registry, ChiCTR2300068380.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the per-protocol analysis, IgG antibody response reached 100% seroconversion by day 30 after the second vaccination. Antibody levels were comparable among different vaccine groups under the same schedule at day 30 post-second vaccination. The occurrence of adverse reactions was similar among the different vaccine groups within the same schedule. Most adverse reactions were mild or moderate and resolved shortly. None of the serious adverse events were related to the vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The 2-dose regimens of v7D vaccine demonstrated robust immune responses and excellent safety profiles. These findings warrant further evaluation of the safety advantages and efficacy v7D vaccine in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005184","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:00:35Z","timestamp":1771390835000},"page":"733-741","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial"],"prefix":"10.1097","volume":"45","author":[{"given":"Lingxian","family":"Qiu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ganyu County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Ganyu County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Liao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxue","family":"Li","sequence":"additional","affiliation":[{"name":"Ganyu County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Xu","sequence":"additional","affiliation":[{"name":"Ganyu County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Zhuang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujie","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinle","family":"Han","sequence":"additional","affiliation":[{"name":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Jia","sequence":"additional","affiliation":[{"name":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiafei","family":"Chu","sequence":"additional","affiliation":[{"name":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Su","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Ye","sequence":"additional","affiliation":[{"name":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Quan","sequence":"additional","affiliation":[{"name":"National Institute for Food and Drug Control, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-9180","authenticated-orcid":false,"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian, China"},{"name":"National Institute of Diagnostics and Vaccine Development in Infectious Diseases, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, Fujian, China"},{"name":"The Research Unit of Frontier Technology of Structural Vaccinology, Chinese Academy of Medical Sciences, Xiamen University, Xiamen, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella.","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/INF.0000000000001249","article-title":"Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010.","volume":"35","author":"Civen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003-2014.","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"issue":"Supplement_4","key":"R4-20260706","doi-asserted-by":"crossref","first-page":"S431","DOI":"10.1093\/infdis\/jiac306","article-title":"Safety surveillance of varicella vaccines in the vaccine adverse event reporting system, United States, 2006\u20132020.","volume":"226","author":"Moro","year":"2022","journal-title":"J Infect Dis"},{"issue":"27\/28","key":"R5-20260706","first-page":"265","article-title":"WHO position paper on herpes zoster vaccines\u2013July 2025 [Note de synth\u00e8se: position de l\u2019OMS sur les vaccins contre le zona\u2013juillet 2025].","volume":"100","author":"Mondiale de la Sant\u00e9","year":"2025","journal-title":"Wkly Epidemiol Rec [REH]"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"e2538","DOI":"10.1002\/rmv.2538","article-title":"Serious neurological adverse events in immunocompetent children and adolescents caused by viral reactivation in the years following varicella vaccination.","volume":"34","author":"Ramachandran","year":"2024","journal-title":"Rev Med Virol"},{"key":"R7-20260706","doi-asserted-by":"crossref","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","article-title":"Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.","volume":"6","author":"Zhang","year":"2010","journal-title":"PLoS Pathog"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1128\/JVI.00128-12","article-title":"ORF7 of varicella-zoster virus is a neurotropic factor.","volume":"86","author":"Selariu","year":"2012","journal-title":"J Virol"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41467-022-28329-1","article-title":"Development of a skin- and neuro-attenuated live vaccine for varicella.","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"R10-20260706","first-page":"100707","article-title":"Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.","volume":"34","author":"Mo","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1473-3099(24)00159-2","article-title":"Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.","volume":"24","author":"Pan","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine.","volume":"291","author":"V\u00e1zquez","year":"2004","journal-title":"JAMA"},{"key":"R13-20260706","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R14-20260706","first-page":"1","article-title":"Varicella vaccination two-dose recommendations.","volume":"36","author":"Tan","year":"2010","journal-title":"Can Commun Dis Rep"},{"key":"R15-20260706","first-page":"59.e1","article-title":"Immunization schedule of the Pediatric Spanish Association: 2022 recommendations.","volume":"96","author":"Garc\u00eda","year":"2022","journal-title":"An Pediatr (Engl Ed)"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3345\/cep.2021.01564","article-title":"Global varicella vaccination programs.","volume":"65","author":"Lee","year":"2022","journal-title":"Clin Exp Pediatr"},{"key":"R17-20260706","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs.","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/ITT.S176383","article-title":"Varicella zoster virus vaccines: an update.","volume":"8","author":"Gabutti","year":"2019","journal-title":"Immunotargets Ther"},{"key":"R19-20260706","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20260706","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1186\/s12889-023-16304-4","article-title":"The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study.","volume":"23","author":"Qiu","year":"2023","journal-title":"BMC Public Health"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3476(95)70106-0","article-title":"Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine.","volume":"127","author":"Krause","year":"1995","journal-title":"J Pediatr"},{"issue":"4 Pt 1","key":"R22-20260706","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine.","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"R24-20260706","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0163-4453(17)30188-3","article-title":"Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?","volume":"74","author":"Gershon","year":"2017","journal-title":"J Infect"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/74715","article-title":"Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.","volume":"6","author":"Krause","year":"2000","journal-title":"Nat Med"},{"key":"R26-20260706","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol Rev"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:00:56Z","timestamp":1783328456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005184","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}